Table 3.
Antimicrobial susceptibility pattern of isolated organisms from urine samples.
| Organism | Type of antibiotic | Susceptibility level | ||
|---|---|---|---|---|
| Susceptible | Intermediate | Resistant | ||
| E. coli | Imipenem | 514 (100%) | 0 (0%) | 0 (0%) |
| Amikacin | 483 (94.2%) | 10 (1.9%) | 20 (3.9%) | |
| Nitrofurantoin | 445 (90.1%) | 22 (4.5%) | 27 (5.5%) | |
| Gentamicin | 370 (71.8%) | 23 (4.5%) | 122 (23.7%) | |
| Cefepime | 322 (63%) | 25 (4.9%) | 164 (32.1%) | |
| Ceftazidime | 301 (58.7%) | 21 (4.1%) | 191 (37.2%) | |
| Ceftriaxone | 289 (57%) | 23 (4.5%) | 195 (38.5%) | |
| Ciprofloxacin | 286 (55.6%) | 35 (6.8%) | 193 (37.5%) | |
| Cotrimoxazole | 224 (47.1%) | 17 (3.6%) | 235 (49.4%) | |
| Cephalothin | 145 (28.4%) | 77 (15.1%) | 289 (56.6%) | |
|
| ||||
| Klebsiella | Imipenem | 57 (100%) | 0 (0%) | 0 (0%) |
| Meropenem | 26 (100%) | 0 (0%) | 0 (0%) | |
| Amikacin | 55 (96.4%) | 0 (0%) | 2 (3.5%) | |
| Ciprofloxacin | 47 (83.9%) | 0 (0%) | 9 (16.1%) | |
| Gentamicin | 46 (80.7%) | 1 (1.8%) | 10 (17.5%) | |
| Cefepime | 41 (71.9%) | 3 (5.3%) | 13 (22.8%) | |
| Ceftazidime | 36 (65.5%) | 1 (1.8%) | 18 (32.7%) | |
| Ceftriaxone | 35 (63.6%) | 4 (7.3%) | 16 (29.1%) | |
| Cotrimoxazole | 34 (63%) | 2 (3.7%) | 18 (33.3%) | |
| Nitrofurantoin | 31 (58.5%) | 8 (15.1%) | 14 (26.4%) | |
| Cephalothin | 30 (54.5%) | 4 (7.3%) | 21 (38.2%) | |
| Ampicillin | 3 (5.6%) | 1 (1.9%) | 50 (92.6%) | |
| Coamoxiclav | 15 (27.3%) | 6 (10.9%) | 34 (61.8%) | |
|
| ||||
| Enterococcus | Nitrofurantoin | 40 (74.1%) | 5 (9.3%) | 9 (16.7%) |
| Gentamicin | 22 (47.8%) | 3 (6.5%) | 21 (45.7%) | |
| Vancomycin | 26 (44.8%) | 0 (0%) | 32 (55.2%) | |
| Cotrimoxazole | 16 (38.1%) | 2 (4.8%) | 24 (57.1%) | |
| Ciprofloxacin | 19 (35.2%) | 16 (29.4%) | 19 (35.2%) | |
| Erythromycin | 16 (27.6%) | 8 (41.4%) | 34 (58.6%) | |
| Clindamycin | 3 (5.9%) | 0 (0%) | 48 (94.1%) | |